FDA Warns Hospira Over Issues At Costa Rican Plant

Law360, New York (August 28, 2012, 7:26 PM EDT) -- Hospira Inc. disclosed on Tuesday that it has received a warning letter from the U.S. Food and Drug Administration regarding quality issues uncovered during an inspection of a Costa Rican facility at which most of the company's infusion devices and sets are manufactured.

In a report filed Tuesday with the U.S. Securities and Exchange Commission, the device maker said it had received a letter on Aug. 23 citing numerous issues at its La Aurora de Heredia, Costa Rica, device manufacturing facility, though it noted that the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.